Both of these factors are thought to attenuate insulin action, in part, by activating pathways that interfere with or oppose insulin signaling and thus they have also been implicated in the development of obesity-induced IR [15–17]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.